In conclusion, our results demonstrate that hyperactive ELA2A from IEC participates to key features of IBD pathogenesis: (i) increased permeability of intestinal epithelial barrier, which leads to penetration of luminal products into the mucosa and (ii) abnormal immune status of epithelial cells leading to chemokine-driven inflammation. Here, CELA2A is linked to inflammatory bowel disease.